Ernexa Therapeutics Inc. Warrants (ERNAW NASDAQ) stock market data APIs
$0.0254
-0(-0%)
as of October 9, 2026
Try our APIs with
free plan!
Ernexa Therapeutics Inc. Warrants Financial Data Overview
Price chart is built with
Anychart
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Prev. Close
0.0254
Open
0.0253
High
0.0319
Low
0.0251
52 wk Range
0.0213-0.2278
Market Cap
0
Revenue
1 000
Beta
2.646
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at €19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only €19.99
TRY NOW
Get Ernexa Therapeutics Inc. Warrants data using free add-ons & libraries
Get Ernexa Therapeutics Inc. Warrants Fundamental Data
Ernexa Therapeutics Inc. Warrants Fundamental data includes:
- Net Revenue: 1 000
- EBITDA: -11 691 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
€
59.99
/mo.
End-of-day & Earnings data
Get Ernexa Therapeutics Inc. Warrants Earnings data
Corporate Events Calendar & News package for
€
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ernexa Therapeutics Inc. Warrants News
Get Ernexa Therapeutics Inc. Warrants fresh news feed via Financial News API
Corporate Events Calendar & News package for
€19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only €19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
€99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.